Pharmacokinetics Study of Oral 2-Deoxy-D-Glucose (2DG) in Subjects With a Confirmed Diagnosis of Epilepsy
Clinical trial NCT05605301 · COMPLETED
Trial details
- NCT number
- NCT05605301
- Sponsor
- University of Virginia
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-02
- Primary completion
- 2024-02-05
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.